GROUP ONE TRADING, L.P. - BENITEC BIOPHARMA INC ownership

BENITEC BIOPHARMA INC's ticker is BNTC and the CUSIP is 08205P100. A total of 26 filers reported holding BENITEC BIOPHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of BENITEC BIOPHARMA INC
ValueSharesWeighting
Q2 2023$358
+13.7%
1,5000.0%0.00%
Q1 2023$315
+23.5%
1,5000.0%0.00%
Q4 2022$255
-74.5%
1,500
-11.8%
0.00%
Q3 2022$1,000
-50.0%
1,700
-15.0%
0.00%
Q2 2022$2,000
-60.0%
2,0000.0%0.00%
Q1 2022$5,0000.0%2,0000.0%0.00%
Q4 2021$5,000
-28.6%
2,0000.0%0.00%
Q3 2021$7,0002,0000.00%
Other shareholders
BENITEC BIOPHARMA INC shareholders Q3 2022
NameSharesValueWeighting ↓
Empery Asset Management, LP 796,837$296,0001.76%
Altium Capital Management LP 658,796$245,0000.09%
CVI Holdings, LLC 1,289,128$479,0000.04%
SUVRETTA CAPITAL MANAGEMENT, LLC 769,000$286,0000.01%
ARMISTICE CAPITAL, LLC 1,555,039$578,0000.01%
FRANKLIN RESOURCES INC 10,000,000$3,717,0000.00%
WealthTrust Axiom LLC 12,950$4,0000.00%
CANTOR FITZGERALD, L. P. 133,805$50,0000.00%
Walleye Capital LLC 190,678$71,0000.00%
UBS Group AG 28,683$11,0000.00%
View complete list of BENITEC BIOPHARMA INC shareholders